ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update
July 22, 2014 at 07:02 AM EDT
ZIOPHARM Oncology, Inc. ("ZIOPHARM") (Nasdaq: ZIOP), a biopharmaceutical company focused on the development and commercialization of ...
